Jazz Pharmaceuticals (JAZZ) Competitors $133.34 -0.47 (-0.35%) As of 12:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock JAZZ vs. AXSM, RPRX, CORT, PRGO, SUPN, NKTR, PCRX, OMER, ASMB, and CPIXShould you be buying Jazz Pharmaceuticals stock or one of its competitors? The main competitors of Jazz Pharmaceuticals include Axsome Therapeutics (AXSM), Royalty Pharma (RPRX), Corcept Therapeutics (CORT), Perrigo (PRGO), Supernus Pharmaceuticals (SUPN), Nektar Therapeutics (NKTR), Pacira BioSciences (PCRX), Omeros (OMER), Assembly Biosciences (ASMB), and Cumberland Pharmaceuticals (CPIX). These companies are all part of the "medical" sector. Jazz Pharmaceuticals vs. Its Competitors Axsome Therapeutics Royalty Pharma Corcept Therapeutics Perrigo Supernus Pharmaceuticals Nektar Therapeutics Pacira BioSciences Omeros Assembly Biosciences Cumberland Pharmaceuticals Axsome Therapeutics (NASDAQ:AXSM) and Jazz Pharmaceuticals (NASDAQ:JAZZ) are both mid-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations, institutional ownership and media sentiment. Do insiders & institutionals believe in AXSM or JAZZ? 81.5% of Axsome Therapeutics shares are owned by institutional investors. Comparatively, 89.1% of Jazz Pharmaceuticals shares are owned by institutional investors. 22.4% of Axsome Therapeutics shares are owned by company insiders. Comparatively, 4.3% of Jazz Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Do analysts recommend AXSM or JAZZ? Axsome Therapeutics currently has a consensus price target of $177.93, indicating a potential upside of 38.63%. Jazz Pharmaceuticals has a consensus price target of $178.93, indicating a potential upside of 34.20%. Given Axsome Therapeutics' stronger consensus rating and higher probable upside, equities analysts clearly believe Axsome Therapeutics is more favorable than Jazz Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Axsome Therapeutics 1 Sell rating(s) 0 Hold rating(s) 14 Buy rating(s) 2 Strong Buy rating(s) 3.00Jazz Pharmaceuticals 1 Sell rating(s) 2 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.76 Does the media prefer AXSM or JAZZ? In the previous week, Axsome Therapeutics had 12 more articles in the media than Jazz Pharmaceuticals. MarketBeat recorded 38 mentions for Axsome Therapeutics and 26 mentions for Jazz Pharmaceuticals. Jazz Pharmaceuticals' average media sentiment score of 0.70 beat Axsome Therapeutics' score of 0.45 indicating that Jazz Pharmaceuticals is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Axsome Therapeutics 12 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Jazz Pharmaceuticals 10 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, AXSM or JAZZ? Axsome Therapeutics has a beta of 0.52, indicating that its stock price is 48% less volatile than the S&P 500. Comparatively, Jazz Pharmaceuticals has a beta of 0.28, indicating that its stock price is 72% less volatile than the S&P 500. Is AXSM or JAZZ more profitable? Jazz Pharmaceuticals has a net margin of -9.91% compared to Axsome Therapeutics' net margin of -49.88%. Jazz Pharmaceuticals' return on equity of 5.02% beat Axsome Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Axsome Therapeutics-49.88% -283.22% -33.06% Jazz Pharmaceuticals -9.91%5.02%1.73% Which has better earnings & valuation, AXSM or JAZZ? Jazz Pharmaceuticals has higher revenue and earnings than Axsome Therapeutics. Axsome Therapeutics is trading at a lower price-to-earnings ratio than Jazz Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAxsome Therapeutics$385.69M16.61-$287.22M-$5.07-25.32Jazz Pharmaceuticals$4.09B1.98$560.12M-$6.73-19.81 SummaryAxsome Therapeutics and Jazz Pharmaceuticals tied by winning 8 of the 16 factors compared between the two stocks. Get Jazz Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for JAZZ and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding JAZZ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JAZZ vs. The Competition Export to ExcelMetricJazz PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.09B$3.40B$6.05B$10.50BDividend YieldN/A2.30%5.73%4.80%P/E Ratio-19.8122.8585.1627.28Price / Sales1.98269.65518.10200.08Price / Cash4.4546.9537.5761.53Price / Book1.9710.5412.406.82Net Income$560.12M-$52.58M$3.32B$276.69M7 Day Performance-3.23%0.57%0.52%0.18%1 Month Performance6.48%15.45%10.05%8.18%1 Year Performance13.69%17.98%75.51%34.82% Jazz Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JAZZJazz Pharmaceuticals4.591 of 5 stars$133.34-0.4%$178.93+34.2%+20.5%$8.09B$4.09B-19.812,800Analyst RevisionAXSMAxsome Therapeutics4.7016 of 5 stars$121.15-0.5%$177.93+46.9%+44.6%$6.05B$495.03M-23.90380Analyst RevisionRPRXRoyalty Pharma4.91 of 5 stars$35.44-1.6%$46.00+29.8%+29.2%$20.67B$2.31B20.4980CORTCorcept Therapeutics4.8998 of 5 stars$71.53-3.3%$135.25+89.1%+59.2%$7.54B$716.08M63.30300PRGOPerrigo4.8795 of 5 stars$21.23-0.1%$34.00+60.2%-10.4%$2.92B$4.33B-36.608,379SUPNSupernus Pharmaceuticals4.1554 of 5 stars$48.38-1.3%$64.00+32.3%+49.5%$2.71B$661.82M42.07580NKTRNektar Therapeutics4.0662 of 5 stars$57.40+5.6%$91.67+59.7%+188.3%$1.09B$98.43M-6.52220Positive NewsPCRXPacira BioSciences3.7845 of 5 stars$22.26-0.4%$33.40+50.0%+39.3%$1.00B$705.85M-8.01720Positive NewsOMEROmeros3.7424 of 5 stars$4.19flat$18.00+329.6%+3.3%$285.16MN/A-1.99210News CoverageAnalyst ForecastGap UpASMBAssembly Biosciences3.7046 of 5 stars$27.66+4.3%$41.25+49.1%+66.9%$212.15M$28.52M-4.96100News CoverageAnalyst ForecastHigh Trading VolumeCPIXCumberland Pharmaceuticals1.0892 of 5 stars$3.36-2.6%N/A+158.0%$50.27M$37.87M-15.2780 Related Companies and Tools Related Companies AXSM Alternatives RPRX Alternatives CORT Alternatives PRGO Alternatives SUPN Alternatives NKTR Alternatives PCRX Alternatives OMER Alternatives ASMB Alternatives CPIX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:JAZZ) was last updated on 10/15/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jazz Pharmaceuticals PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Jazz Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
